Insider TradingJul 22, 2026, 07:06 AM
OKYO Pharma CMO Buys 20,000 Shares for $28,000
AI Summary
OKYO Pharma's Chief Medical Officer, Flavio Mantelli, MD, PhD, purchased 20,000 ordinary shares of the company on July 22, 2026. The shares were acquired on NASDAQ at a price of $1.40 per share, totaling $28,000. This insider transaction signals management's confidence in the company's prospects.
Key Highlights
- OKYO Pharma's Chief Medical Officer, Flavio Mantelli, purchased shares.
- Acquired 20,000 ordinary shares of the company.
- Shares purchased on NASDAQ at $1.40 per share.
- Total transaction value amounted to $28,000.
- The purchase was made on July 22, 2026.
Price Impact
More from OKYO